SIGA Technologies (SIGA)

Common Shares
Sell: $7.37|Buy: $7.47|Change: 0.01 (0.13%)

Open 

$7.39


Previous close 

$7.45


Trade high 

$7.535


Volume 

436,060


Year high 

$10.83


Year low 

$4.22


Dividend yield 

-


Market capitalisation 

$530.57 mn


P/E ratio 

6.78


ISIN 

US8269171067


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Performance 24/05/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
SIGA Technologies+ 0.13
More...

Company profile

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.